The head of the World Health Organization (WHO) welcomed A decision of the United States In support of the intellectual property waiver for the coronavirus vaccine, it has been hailed as “a memorable moment” in the fight against the deadly virus.
On Wednesday, WHO Executive Director Tedros Adhanom Ghebreysas praised the Biden administration’s support for waiving intellectual property rights as an example of “leadership in tackling global health challenges.”
U.S. President Joe Biden faced pressure to support the World Trade Organization’s (WTO) proposal to waive patents, a move that could produce more COVID-19 jobs needed by more countries.
Tedros tweeted, “Now let’s all come together, based on the expertise and commitment of the scientists who developed the life-saving #CVID 19 vaccine.”
This is a memorable moment in the fight against # COVID-19. By promise Potash Joe Biden and On Twitter That ambuster Supporting the IP protection waiver on vaccines is a powerful example of leadership in tackling global health challenges. pic.twitter.com/3iBt3jfdEr
– Tedros adhanum gherbias (@DRTidros) May 5, 2021
Biden, who supervised A quick roll out of COVID-19 vaccines In the United States, Global Vaccine has faced increasing calls for equity support and more to share the country’s vaccine supply with other affected countries.
Dozens of countries, as well as rights groups, former world leaders and public health experts have called for their patent waivers in recent weeks amid the outbreak of deadly COVID-19 in several countries.
In a statement earlier on Tuesday, US Trade Representative Katherine Tay said Washington would take part in talks with the WTO on the waiver.
“This discussion will take time due to the sensory nature of the organization and the complexity of the issues involved,” he said.
Over the weekend, White House Chief of Staff Ron Klein said he would discuss with the WTO how to make the vaccine more comprehensive, more widely licensed, more widely distributed.
Mike Hannah of Al Jazeera, published from Washington, D.C., says Biden is under pressure from members of his own Democratic Party to revoke the vaccine patent.
“This is something that President Biden promised during his campaign,” Hannah said. “However, whenever he comes to the office, there is a lot of pressure from many pharmaceutical companies not to carry this discount.”
He added that the WTO, which operates on a quantitative basis, must now come together for a text discussion that all member states must agree on.
“Obviously, there is a lot of work to be done before it becomes a reality … but the decision of the Beadon administration is something that gives this huge momentum.
Worldwide call for remission
South Africa and India in October last year Request More to the WTO for waiving intellectual property rights over vaccines and other treatment technologies needed to combat the coronavirus 100 other countries Supported that call.
“Given the current context of the global emergency, it is important for WTO members to work together to ensure that intellectual property rights, such as patents, industrial designs, copyrights and the protection of anonymous information, do not hinder timely access to affordable medical products,” the October letter read.
Demands for emergency waivers have increased as several countries, including India, have been dealing with it Destructive COVID-19 surges.
In April, the non-governmental organization Doctors Without Borders A call to rich countries Patent waiver “standing on the right side of history and joining hands with supporters”
Following the US announcement, the International Federation of Pharmaceutical Manufacturers and Associations called for an “incorrect answer” to a complex problem without patents for the COVID-19 vaccine and for a further technology transfer agreement, Reuters news agency reported.
“The issuance of patents for the COVID-19 vaccine will not require increased production or practical solutions to this global health crisis. On the contrary, it is likely to be disrupted, “the IFPMA, which represents research-based pharmaceutical companies, said in a statement.
Others, along with British Labor MP Bell Ribeiro-Adi, welcomed the Beadon administration’s move. Calling The UK government has been “backed by the IP waiver” to speed up the vaccine rollout in low-income countries and limit the possibility of new forms emerging.
At the current rate of vaccine delivery, it will take about two years for most adults to get tested against COVD-19, said Julie Fisher, an associate research professor at Georgetown University Medical Center.
Fisher told Al Jazeera: “The question is, will the issue of waiving this intellectual property right be resolved as soon as everyone wants to see it.”
He explained that even countries with the ability to make vaccines would need production facilities, access to raw materials, and the skills needed to prepare safe doses in a short period of time.
“We have the opportunity to see what we can do to ramp up current vaccine production capacity more efficiently and to further share doses from high-income countries to low-income countries with the Covax facility,” Fisher said. WHO Vaccine Distribution Program.